Skip to main content
Erschienen in: Inflammation Research 1/2015

01.01.2015 | Original Research Paper

Low-dose mercury heightens early innate response to coxsackievirus infection in female mice

verfasst von: Kayla L. Penta, DeLisa Fairweather, Devon L. Shirley, Noel R. Rose, Ellen K. Silbergeld, Jennifer F. Nyland

Erschienen in: Inflammation Research | Ausgabe 1/2015

Einloggen, um Zugang zu erhalten

Abstract

Objective

Mercury is a ubiquitous environmental contaminant with toxic outcomes over a range of exposures. In this study, we investigated the effects of mercury exposure on early immune responses to coxsackievirus B3 (CVB3) infection in a murine model of autoimmune heart disease.

Materials and methods

Female BALB/c mice, susceptible to CVB3-induced autoimmune myocarditis, were treated with mercuric chloride (200 μg/kg body weight every other day for 2 weeks) prior to infection with CVB3. Six hours post-infection, immune cells were isolated from the spleen and peritoneum for flow cytometry, gene expression, and cytokine profiling. Thirty-five days post-infection, hearts were collected for histological examination of immune cell infiltration.

Results

As for male mice, mercury exposure significantly increased autoimmune myocarditis and immune infiltration into the heart. During the innate response 6 h post-infection, mercury increased expression of co-stimulatory molecules and innate immune receptors on peritoneal macrophages. At the same time point, the alternatively activated macrophage gene, arginase, was increased while the classically activated macrophage gene, inducible nitric oxide synthase, was unaffected. Expression of activation markers were decreased on peritoneal B cells with mercury exposure while T cells were unaffected. Mercury increased production of pro-inflammatory mediators in the spleen. Macrophage-recruiting chemokines and activating cytokines, such as CCL2, CCL4, and IL-6, were increased with mercury following CVB3 infection.

Conclusions

Thus, mercury treatment exacerbates autoimmune myocarditis in female mice and alters early innate signaling on peritoneal macrophages. Mercury also modulates the cytokine profile in the spleen toward a macrophage-activating milieu, and upregulates alternatively activated macrophage genes, providing evidence that mercury exposure promotes inflammation in the context of infection.
Literatur
1.
Zurück zum Zitat Mahaffey KR, Clickner RP, Bodurow CC. Blood organic mercury and dietary mercury intake: national health and nutrition examination survey, 1999 and 2000. Environ Health Perspect. 2004;112(5):562–70.PubMedCentralPubMedCrossRef Mahaffey KR, Clickner RP, Bodurow CC. Blood organic mercury and dietary mercury intake: national health and nutrition examination survey, 1999 and 2000. Environ Health Perspect. 2004;112(5):562–70.PubMedCentralPubMedCrossRef
2.
Zurück zum Zitat Gochfeld M. Cases of mercury exposure, bioavailability, and absorption. Ecotoxicol Environ Saf. 2003;56(1):174–9.PubMedCrossRef Gochfeld M. Cases of mercury exposure, bioavailability, and absorption. Ecotoxicol Environ Saf. 2003;56(1):174–9.PubMedCrossRef
3.
Zurück zum Zitat NRC. Toxicological effects of methyl mercury. Washington, DC: National Academy Press; 2000. NRC. Toxicological effects of methyl mercury. Washington, DC: National Academy Press; 2000.
4.
Zurück zum Zitat Cooper GS, Parks CG, Treadwell EL. St Clair EW, Gilkeson GS, Dooley MA. Occupational risk factors for the development of systemic lupus erythematosus. J Rheumatol. 2004;31(10):1928–33.PubMed Cooper GS, Parks CG, Treadwell EL. St Clair EW, Gilkeson GS, Dooley MA. Occupational risk factors for the development of systemic lupus erythematosus. J Rheumatol. 2004;31(10):1928–33.PubMed
5.
Zurück zum Zitat Silva IA, Nyland JF, Gorman A, Perisse A, Ventura AM, Santos EC, et al. Mercury exposure, malaria, and serum antinuclear/antinucleolar antibodies in amazon populations in Brazil: a cross-sectional study. Environ Health. 2004;3(1):11–22.PubMedCentralPubMedCrossRef Silva IA, Nyland JF, Gorman A, Perisse A, Ventura AM, Santos EC, et al. Mercury exposure, malaria, and serum antinuclear/antinucleolar antibodies in amazon populations in Brazil: a cross-sectional study. Environ Health. 2004;3(1):11–22.PubMedCentralPubMedCrossRef
6.
Zurück zum Zitat Alves MF, Fraiji NA, Barbosa AC, De Lima DS, Souza JR, Dorea JG, et al. Fish consumption, mercury exposure and serum antinuclear antibody in Amazonians. Int J Environ Health Res. 2006;16(4):255–62.PubMedCrossRef Alves MF, Fraiji NA, Barbosa AC, De Lima DS, Souza JR, Dorea JG, et al. Fish consumption, mercury exposure and serum antinuclear antibody in Amazonians. Int J Environ Health Res. 2006;16(4):255–62.PubMedCrossRef
11.
Zurück zum Zitat Hultman P, Nielsen JB. The effect of dose, gender, and non-H-2 genes in murine mercury-induced autoimmunity. J Autoimmun. 2001;17(1):27–37.PubMedCrossRef Hultman P, Nielsen JB. The effect of dose, gender, and non-H-2 genes in murine mercury-induced autoimmunity. J Autoimmun. 2001;17(1):27–37.PubMedCrossRef
12.
Zurück zum Zitat Monestier M, Losman MJ, Novick KE, Aris JP. Molecular analysis of mercury-induced antinucleolar antibodies in H-2S mice. J Immunol. 1994;152(2):667–75.PubMed Monestier M, Losman MJ, Novick KE, Aris JP. Molecular analysis of mercury-induced antinucleolar antibodies in H-2S mice. J Immunol. 1994;152(2):667–75.PubMed
14.
Zurück zum Zitat Robinson CJ, White HJ, Rose NR. Murine strain differences in response to mercuric chloride: antinucleolar antibodies production does not correlate with renal immune complex deposition. Clin Immunol Immunopathol. 1997;83(2):127–38.PubMedCrossRef Robinson CJ, White HJ, Rose NR. Murine strain differences in response to mercuric chloride: antinucleolar antibodies production does not correlate with renal immune complex deposition. Clin Immunol Immunopathol. 1997;83(2):127–38.PubMedCrossRef
15.
Zurück zum Zitat Pollard KM, Pearson DL, Hultman P, Deane TN, Lindh U, Kono DH. Xenobiotic acceleration of idiopathic systemic autoimmunity in lupus- prone bxsb mice. Environ Health Perspect. 2001;109(1):27–33.PubMedCentralPubMedCrossRef Pollard KM, Pearson DL, Hultman P, Deane TN, Lindh U, Kono DH. Xenobiotic acceleration of idiopathic systemic autoimmunity in lupus- prone bxsb mice. Environ Health Perspect. 2001;109(1):27–33.PubMedCentralPubMedCrossRef
16.
Zurück zum Zitat Via CS, Nguyen P, Niculescu F, Papadimitriou J, Hoover D, Silbergeld EK. Low-dose exposure to inorganic mercury accelerates disease and mortality in acquired murine lupus. Environ Health Perspect. 2003;111(10):1273–7.PubMedCentralPubMedCrossRef Via CS, Nguyen P, Niculescu F, Papadimitriou J, Hoover D, Silbergeld EK. Low-dose exposure to inorganic mercury accelerates disease and mortality in acquired murine lupus. Environ Health Perspect. 2003;111(10):1273–7.PubMedCentralPubMedCrossRef
17.
18.
Zurück zum Zitat Silbergeld EK, Silva IA, Nyland JF. Mercury and autoimmunity: implications for occupational and environmental health. Toxicol Appl Pharmacol. 2005;207(2 Suppl):282–92.PubMedCrossRef Silbergeld EK, Silva IA, Nyland JF. Mercury and autoimmunity: implications for occupational and environmental health. Toxicol Appl Pharmacol. 2005;207(2 Suppl):282–92.PubMedCrossRef
19.
Zurück zum Zitat Frisancho-Kiss S, Davis SE, Nyland JF, Frisancho JA, Cihakova D, Barrett MA, et al. Cutting edge: cross-regulation by TLR4 and T cell Ig mucin-3 determines sex differences in inflammatory heart disease. J Immunol. 2007;178(11):6710–4.PubMedCrossRef Frisancho-Kiss S, Davis SE, Nyland JF, Frisancho JA, Cihakova D, Barrett MA, et al. Cutting edge: cross-regulation by TLR4 and T cell Ig mucin-3 determines sex differences in inflammatory heart disease. J Immunol. 2007;178(11):6710–4.PubMedCrossRef
20.
Zurück zum Zitat Frisancho-Kiss S, Nyland JF, Davis SE, Barrett MA, Gatewood SJ, Njoku DB, et al. Cutting edge: T cell Ig mucin-3 reduces inflammatory heart disease by increasing CTLA-4 during innate immunity. J Immunol. 2006;176(11):6411–5.PubMedCrossRef Frisancho-Kiss S, Nyland JF, Davis SE, Barrett MA, Gatewood SJ, Njoku DB, et al. Cutting edge: T cell Ig mucin-3 reduces inflammatory heart disease by increasing CTLA-4 during innate immunity. J Immunol. 2006;176(11):6411–5.PubMedCrossRef
22.
Zurück zum Zitat Lawrence DA, McCabe MJ Jr. Immunomodulation by metals. Int Immunopharmacol. 2002;2(2–3):293–302.PubMedCrossRef Lawrence DA, McCabe MJ Jr. Immunomodulation by metals. Int Immunopharmacol. 2002;2(2–3):293–302.PubMedCrossRef
23.
Zurück zum Zitat Fairweather D, Rose NR. Coxsackievirus-induced myocarditis in mice: a model of autoimmune disease for studying immunotoxicity. Methods. 2007;41(1):118–22.PubMedCentralPubMedCrossRef Fairweather D, Rose NR. Coxsackievirus-induced myocarditis in mice: a model of autoimmune disease for studying immunotoxicity. Methods. 2007;41(1):118–22.PubMedCentralPubMedCrossRef
25.
Zurück zum Zitat Fairweather D, Yusung S, Frisancho S, Barrett M, Gatewood S, Steele R, et al. IL-12 Receptor beta1 and Toll-Like Receptor 4 Increase IL-1beta- and IL-18-Associated Myocarditis and Coxsackievirus Replication. J Immunol. 2003;170(9):4731–7.PubMedCrossRef Fairweather D, Yusung S, Frisancho S, Barrett M, Gatewood S, Steele R, et al. IL-12 Receptor beta1 and Toll-Like Receptor 4 Increase IL-1beta- and IL-18-Associated Myocarditis and Coxsackievirus Replication. J Immunol. 2003;170(9):4731–7.PubMedCrossRef
26.
Zurück zum Zitat Fairweather D, Frisancho S, Gatewood S, Njoku D, Steele R, Barrett M, et al. Mast cells and innate cytokines are associated with susceptibility to autoimmune heart disease following Coxsackievirus B3 infection. Autoimmunity. 2004;37:131–45.PubMedCrossRef Fairweather D, Frisancho S, Gatewood S, Njoku D, Steele R, Barrett M, et al. Mast cells and innate cytokines are associated with susceptibility to autoimmune heart disease following Coxsackievirus B3 infection. Autoimmunity. 2004;37:131–45.PubMedCrossRef
27.
Zurück zum Zitat Schiraldi M, Monestier M. How can a chemical element elicit complex immunopathology? Lessons from mercury-induced autoimmunity. Trends Immunol. 2009;30(10):502–9.PubMedCrossRef Schiraldi M, Monestier M. How can a chemical element elicit complex immunopathology? Lessons from mercury-induced autoimmunity. Trends Immunol. 2009;30(10):502–9.PubMedCrossRef
28.
Zurück zum Zitat Ilback NG, Wesslen L, Fohlman J, Friman G. Effects of methyl mercury on cytokines, inflammation and virus clearance in a common infection (coxsackie B3 myocarditis). Toxicol Lett. 1996;89(1):19–28.PubMedCrossRef Ilback NG, Wesslen L, Fohlman J, Friman G. Effects of methyl mercury on cytokines, inflammation and virus clearance in a common infection (coxsackie B3 myocarditis). Toxicol Lett. 1996;89(1):19–28.PubMedCrossRef
29.
Zurück zum Zitat Johansson U, Sander B, Hultman P. Effects of the murine genotype on T cell activation and cytokine production in murine mercury-induced autoimmunity. J Autoimmun. 1997;10(4):347–55.PubMedCrossRef Johansson U, Sander B, Hultman P. Effects of the murine genotype on T cell activation and cytokine production in murine mercury-induced autoimmunity. J Autoimmun. 1997;10(4):347–55.PubMedCrossRef
30.
Zurück zum Zitat Kono DH, Balomenos D, Pearson DL, Park MS, Hildebrandt B, Hultman P, et al. The prototypic Th2 autoimmunity induced by mercury is dependent on IFN- gamma and not Th1/Th2 imbalance. J Immunol. 1998;161(1):234–40.PubMed Kono DH, Balomenos D, Pearson DL, Park MS, Hildebrandt B, Hultman P, et al. The prototypic Th2 autoimmunity induced by mercury is dependent on IFN- gamma and not Th1/Th2 imbalance. J Immunol. 1998;161(1):234–40.PubMed
31.
Zurück zum Zitat Pollard KM, Hultman P. Effects of mercury on the immune system. Met Ions Biol Syst. 1997;34:421–40.PubMed Pollard KM, Hultman P. Effects of mercury on the immune system. Met Ions Biol Syst. 1997;34:421–40.PubMed
32.
Zurück zum Zitat Hultman P, Bell LJ, Enestrom S, Pollard KM. Murine susceptibility to mercury. I. Autoantibody profiles and systemic immune deposits in inbred, congenic, and intra-H-2 recombinant strains. Clin Immunol Immunopathol. 1992;65(2):98–109.PubMedCrossRef Hultman P, Bell LJ, Enestrom S, Pollard KM. Murine susceptibility to mercury. I. Autoantibody profiles and systemic immune deposits in inbred, congenic, and intra-H-2 recombinant strains. Clin Immunol Immunopathol. 1992;65(2):98–109.PubMedCrossRef
33.
Zurück zum Zitat Abedi-Valugerdi M, Nilsson C, Zargari A, Gharibdoost F, DePierre JW, Hassan M. Bacterial lipopolysaccharide both renders resistant mice susceptible to mercury-induced autoimmunity and exacerbates such autoimmunity in susceptible mice. Clin Exp Immunol. 2005;141(2):238–47.PubMedCentralPubMedCrossRef Abedi-Valugerdi M, Nilsson C, Zargari A, Gharibdoost F, DePierre JW, Hassan M. Bacterial lipopolysaccharide both renders resistant mice susceptible to mercury-induced autoimmunity and exacerbates such autoimmunity in susceptible mice. Clin Exp Immunol. 2005;141(2):238–47.PubMedCentralPubMedCrossRef
34.
Zurück zum Zitat Hansson M, Djerbi M, Rabbani H, Mellstedt H, Gharibdoost F, Hassan M, et al. Exposure to mercuric chloride during the induction phase and after the onset of collagen-induced arthritis enhances immune/autoimmune responses and exacerbates the disease in DBA/1 mice. Immunology. 2005;114(3):428–37.PubMedCentralPubMedCrossRef Hansson M, Djerbi M, Rabbani H, Mellstedt H, Gharibdoost F, Hassan M, et al. Exposure to mercuric chloride during the induction phase and after the onset of collagen-induced arthritis enhances immune/autoimmune responses and exacerbates the disease in DBA/1 mice. Immunology. 2005;114(3):428–37.PubMedCentralPubMedCrossRef
36.
Zurück zum Zitat Kaya Z, Afanasyeva M, Wang Y, Dohmen KM, Schlichting J, Tretter T, et al. Contribution of the innate immune system to autoimmune myocarditis: a role for complement. Nat Immunol. 2001;2(8):739–45.PubMedCrossRef Kaya Z, Afanasyeva M, Wang Y, Dohmen KM, Schlichting J, Tretter T, et al. Contribution of the innate immune system to autoimmune myocarditis: a role for complement. Nat Immunol. 2001;2(8):739–45.PubMedCrossRef
37.
Zurück zum Zitat Fairweather D, Frisancho-Kiss S, Rose NR. Viruses as adjuvants for autoimmunity: evidence from Coxsackievirus-induced myocarditis. Rev Med Virol. 2005;15(1):17–27.PubMedCrossRef Fairweather D, Frisancho-Kiss S, Rose NR. Viruses as adjuvants for autoimmunity: evidence from Coxsackievirus-induced myocarditis. Rev Med Virol. 2005;15(1):17–27.PubMedCrossRef
38.
Zurück zum Zitat Bagenstose LM, Class R, Salgame P, Monestier M. B7-1 and B7-2 co-stimulatory molecules are required for mercury-induced autoimmunity. Clin Exp Immunol. 2002;127(1):12–9.PubMedCentralPubMedCrossRef Bagenstose LM, Class R, Salgame P, Monestier M. B7-1 and B7-2 co-stimulatory molecules are required for mercury-induced autoimmunity. Clin Exp Immunol. 2002;127(1):12–9.PubMedCentralPubMedCrossRef
39.
Zurück zum Zitat Eriksson U, Kurrer MO, Schmitz N, Marsch SC, Fontana A, Eugster HP, et al. Interleukin-6-deficient mice resist development of autoimmune myocarditis associated with impaired upregulation of complement C3. Circulation. 2003;107(2):320–5.PubMedCrossRef Eriksson U, Kurrer MO, Schmitz N, Marsch SC, Fontana A, Eugster HP, et al. Interleukin-6-deficient mice resist development of autoimmune myocarditis associated with impaired upregulation of complement C3. Circulation. 2003;107(2):320–5.PubMedCrossRef
40.
Zurück zum Zitat Fairweather D, Frisancho-Kiss S, Yusung SA, Barrett MA, Davis SE, Steele RA, et al. IL-12 protects against coxsackievirus B3-induced myocarditis by increasing IFN-gamma and macrophage and neutrophil populations in the heart. J Immunol. 2005;174(1):261–9.PubMedCrossRef Fairweather D, Frisancho-Kiss S, Yusung SA, Barrett MA, Davis SE, Steele RA, et al. IL-12 protects against coxsackievirus B3-induced myocarditis by increasing IFN-gamma and macrophage and neutrophil populations in the heart. J Immunol. 2005;174(1):261–9.PubMedCrossRef
41.
Zurück zum Zitat Baldeviano GC, Barin JG, Talor MV, Srinivasan S, Bedja D, Zheng D, et al. Interleukin-17A is dispensable for myocarditis but essential for the progression to dilated cardiomyopathy. Circ Res. 2010;106(10):1646–55.PubMedCrossRef Baldeviano GC, Barin JG, Talor MV, Srinivasan S, Bedja D, Zheng D, et al. Interleukin-17A is dispensable for myocarditis but essential for the progression to dilated cardiomyopathy. Circ Res. 2010;106(10):1646–55.PubMedCrossRef
42.
Zurück zum Zitat Goser S, Ottl R, Brodner A, Dengler TJ, Torzewski J, Egashira K, et al. Critical role for monocyte chemoattractant protein-1 and macrophage inflammatory protein-1alpha in induction of experimental autoimmune myocarditis and effective anti-monocyte chemoattractant protein-1 gene therapy. Circulation. 2005;112(22):3400–7. doi:10.1161/CIRCULATIONAHA.105.572396.PubMedCrossRef Goser S, Ottl R, Brodner A, Dengler TJ, Torzewski J, Egashira K, et al. Critical role for monocyte chemoattractant protein-1 and macrophage inflammatory protein-1alpha in induction of experimental autoimmune myocarditis and effective anti-monocyte chemoattractant protein-1 gene therapy. Circulation. 2005;112(22):3400–7. doi:10.​1161/​CIRCULATIONAHA.​105.​572396.PubMedCrossRef
43.
Zurück zum Zitat Afanasyeva M, Wang Y, Kaya Z, Park S, Zilliox MJ, Schofield BH, et al. Experimental Autoimmune Myocarditis in A/J mice Is an Interleukin-4-Dependent Disease with a Th2 Phenotype. Am J Pathol. 2001;159(1):193–203.PubMedCentralPubMedCrossRef Afanasyeva M, Wang Y, Kaya Z, Park S, Zilliox MJ, Schofield BH, et al. Experimental Autoimmune Myocarditis in A/J mice Is an Interleukin-4-Dependent Disease with a Th2 Phenotype. Am J Pathol. 2001;159(1):193–203.PubMedCentralPubMedCrossRef
44.
Zurück zum Zitat Kaya Z, Dohmen KM, Wang Y, Schlichting J, Afanasyeva M, Leuschner F, et al. Cutting edge: a critical role for IL-10 in induction of nasal tolerance in experimental autoimmune myocarditis. J Immunol. 2002;168(4):1552–6.PubMedCrossRef Kaya Z, Dohmen KM, Wang Y, Schlichting J, Afanasyeva M, Leuschner F, et al. Cutting edge: a critical role for IL-10 in induction of nasal tolerance in experimental autoimmune myocarditis. J Immunol. 2002;168(4):1552–6.PubMedCrossRef
45.
Zurück zum Zitat Fairweather D, Frisancho-Kiss S, Yusung SA, Barrett MA, Davis SE, Gatewood SJ, et al. Interferon-gamma protects against chronic viral myocarditis by reducing mast cell degranulation, fibrosis, and the profibrotic cytokines transforming growth factor-beta 1, interleukin-1 beta, and interleukin-4 in the heart. Am J Pathol. 2004;165(6):1883–94.PubMedCentralPubMedCrossRef Fairweather D, Frisancho-Kiss S, Yusung SA, Barrett MA, Davis SE, Gatewood SJ, et al. Interferon-gamma protects against chronic viral myocarditis by reducing mast cell degranulation, fibrosis, and the profibrotic cytokines transforming growth factor-beta 1, interleukin-1 beta, and interleukin-4 in the heart. Am J Pathol. 2004;165(6):1883–94.PubMedCentralPubMedCrossRef
47.
Zurück zum Zitat Sass JB, Haselow DT, Silbergeld EK. Methylmercury-induced decrement in neuronal migration may involve cytokine-dependent mechanisms: a novel method to assess neuronal movement in vitro. Toxicol Sci. 2001;63(1):74–81.PubMedCrossRef Sass JB, Haselow DT, Silbergeld EK. Methylmercury-induced decrement in neuronal migration may involve cytokine-dependent mechanisms: a novel method to assess neuronal movement in vitro. Toxicol Sci. 2001;63(1):74–81.PubMedCrossRef
48.
Zurück zum Zitat Fairweather D, Rose NR. Models of coxsackievirus-B3-induced myocarditis: recent advances. Drug Discov Today Dis Models. 2004;1(4):381–6.CrossRef Fairweather D, Rose NR. Models of coxsackievirus-B3-induced myocarditis: recent advances. Drug Discov Today Dis Models. 2004;1(4):381–6.CrossRef
49.
Zurück zum Zitat Gardner RM, Nyland JF, Evans SL, Wang SB, Doyle KM, Crainiceanu CM, et al. Mercury induces an unopposed inflammatory response in human peripheral blood mononuclear cells in vitro. Environ Health Perspect. 2009;117(12):1932–8.PubMedCentralPubMedCrossRef Gardner RM, Nyland JF, Evans SL, Wang SB, Doyle KM, Crainiceanu CM, et al. Mercury induces an unopposed inflammatory response in human peripheral blood mononuclear cells in vitro. Environ Health Perspect. 2009;117(12):1932–8.PubMedCentralPubMedCrossRef
Metadaten
Titel
Low-dose mercury heightens early innate response to coxsackievirus infection in female mice
verfasst von
Kayla L. Penta
DeLisa Fairweather
Devon L. Shirley
Noel R. Rose
Ellen K. Silbergeld
Jennifer F. Nyland
Publikationsdatum
01.01.2015
Verlag
Springer Basel
Erschienen in
Inflammation Research / Ausgabe 1/2015
Print ISSN: 1023-3830
Elektronische ISSN: 1420-908X
DOI
https://doi.org/10.1007/s00011-014-0781-x

Weitere Artikel der Ausgabe 1/2015

Inflammation Research 1/2015 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.